Medical disclaimer: This article is for informational purposes only. Mounjaro is a prescription-only medicine in the UK. Always consult a registered healthcare provider before starting any medication.
Mounjaro UK: Everything You Need to Know in 2026
Mounjaro has become the most talked-about weight loss medication in the UK. It produces stronger results than Wegovy in head-to-head clinical trials, it is now available through NHS GP prescribing for the first time, and private prescription prices — while significant — are lower than many people expect from a major UK pharmacy But there is a lot of confusion around it. Is it the same as Zepbound? Can your GP prescribe it? Has the price really gone up 170%? And is it actually better than Wegovy for everyone?
This article answers all of it with the most current UK information available.
What is Mounjaro?
Mounjaro is the brand name for tirzepatide — a once-weekly injectable medication licensed in the UK for both type 2 diabetes and chronic weight management. It is manufactured by Eli Lilly and was approved by the MHRA for weight management in November 2023.
What makes tirzepatide different from semaglutide (Ozempic, Wegovy) is its mechanism. Semaglutide activates one receptor — the GLP-1 receptor. Tirzepatide activates two — the GLP-1 receptor and the GIP receptor simultaneously. GIP stands for glucose-dependent insulinotropic polypeptide, a second gut hormone involved in insulin secretion and fat metabolism. Hitting both pathways at once produces a stronger appetite suppression and more significant weight loss than GLP-1 activation alone.
In clinical trials, Mounjaro produced average weight loss of 20–22% of body weight over 72 weeks — compared to approximately 14–17% for semaglutide. It is currently the most effective weight loss medication licensed in the UK.
Mounjaro vs Zepbound: Are They the Same?
Yes. Mounjaro and Zepbound are identical molecules — tirzepatide — at identical doses. The only difference is the FDA-approved indication in the United States. Mounjaro is the diabetes-approved version, Zepbound is the weight-management approved version.
In the UK, there is only one brand — Mounjaro — and it is licensed for both type 2 diabetes and weight management. There is no separate UK equivalent of Zepbound. When UK sources discuss tirzepatide for weight loss, they are always referring to Mounjaro.
How Much Does Mounjaro Cost in the UK in 2026?
This is where many people get a shock. Eli Lilly raised the UK list price of Mounjaro by up to 170% on 1 September 2025, aligning the UK with other European markets. The 12.5mg and 15mg maintenance doses jumped from £122 to approximately £330 per month at list price. Most private providers passed these increases directly to patients.
Current private prescription prices across the UK market in 2026:
2.5mg starter dose: £120–£220 per month
5mg: £150–£240 per month
7.5mg: £180–£265 per month
10mg: £210–£295 per month
12.5mg: £250–£330 per month
15mg maintenance dose: £270–£340 per month
Prices vary significantly between providers. Asda Online Doctor currently offers some of the most competitive pricing, starting from approximately £149 per month with prescription and aftercare included. Always check whether consultation fees, delivery, and follow-up appointments are included in the quoted price or charged separately — the total cost can differ substantially from the headline figure.
Over a full year at the maintenance dose, you are typically looking at £3,000–£4,000 in medication costs alone.
Is Mounjaro Available on the NHS?
Yes — and the availability expanded significantly in 2026. Here is the timeline:
June 2025: Mounjaro became available on the NHS for weight management for the first time, but access was limited to specialist weight management services with very strict eligibility criteria.
April 2026: NHS Mounjaro prescribing was added to the GP contract as a Quality and Outcomes Framework indicator. This means GPs can now prescribe Mounjaro for obesity within primary care — a major shift from the previous specialist-only model.
June 2026: The BMI threshold for primary care prescribing drops from 40 to 35, with four qualifying conditions. This significantly expands the number of people GPs can prescribe for without a specialist referral.
Despite these expansions, NHS availability still varies significantly by region. Some GP surgeries and ICBs are actively prescribing through the new pathway. Others are still establishing processes. If you want to explore NHS access, the most important step is speaking directly to your GP about the current position in your area.
NHS prescription cost: £9.90 per prescription item in England. Free in Scotland, Wales, and Northern Ireland.
Who Qualifies for Mounjaro in the UK?
NHS eligibility (from June 2026):
BMI of 35 or above with at least four qualifying weight-related health conditions through primary care. BMI of 40 or above without conditions in some pathways. Stricter thresholds apply in some areas — your GP will advise on local criteria.
Private prescription eligibility:
Most UK online clinics require a BMI of 30 or above, or a BMI of 27 or above with at least one weight-related health condition. Some clinics set the threshold at BMI 27 for people with conditions such as type 2 diabetes, hypertension, or cardiovascular disease.
Private eligibility is broader than NHS eligibility — this is why many people who technically qualify for NHS Mounjaro choose private routes to avoid waiting.
Who should not use Mounjaro:
People with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia type 2. People with a history of pancreatitis. Pregnant or breastfeeding women. Anyone with severe gastrointestinal disease. Always disclose your full medical history in the online assessment.
How to Get Mounjaro Privately in the UK
The private route is how the majority of UK patients access Mounjaro in 2026, and the process is straightforward through a regulated online clinic.
Step 1 — Choose a registered UK provider. All legitimate UK providers use GPhC-registered pharmacies and employ UK-registered prescribers. Check that the service is regulated before sharing any medical information.
Step 2 — Complete the online health assessment. This covers your current weight, height, BMI, medical history, existing medications, and any weight-related health conditions. It typically takes 10–20 minutes.
Step 3 — Prescriber review. A UK-registered prescriber reviews your questionnaire — usually within 24 to 48 hours. If you are eligible, a prescription is issued.
Step 4 — Pharmacy dispenses and delivers. The prescription goes to a GPhC-registered pharmacy which prepares and dispatches your medication. Mounjaro requires refrigeration during transit and storage — reputable providers use cold-chain delivery.
Step 5 — Start on 2.5mg. All patients begin on the 2.5mg starter dose regardless of their weight loss goal. The dose increases every 4 weeks as tolerated — 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, and finally 15mg. Rushing the titration schedule is the most common cause of severe side effects.
UK Online Clinics for Mounjaro Private Prescription
Levity UK
Offers Mounjaro alongside Wegovy and Ozempic with personalised clinical support and a structured weight management programme. Available through Awin UK affiliate programme (ID: 106099).
eMed UK
Comprehensive GLP-1 programme including unlimited GP consultations. Flat £100 affiliate commission per referral.
Asda Online Doctor
Competitive private Mounjaro pricing from approximately £149/month including prescription and aftercare. Backed by a major UK pharmacy with established cold-chain logistics.
Juniper UK
Women-focused GLP-1 programme combining Mounjaro with dietitian support, strength training guidance, and a dedicated app. Part of the Eucalyptus group.
Numan
Men-focused health platform offering Mounjaro for weight management alongside clinical oversight.
What to Expect on Mounjaro: Week by Week
Weeks 1–4 (2.5mg):
The starter dose is intentionally low — most people feel relatively mild effects. Some notice reduced appetite within the first week. Nausea is possible but usually manageable at this dose. Use this period to establish new eating habits while appetite suppression begins.
Weeks 5–8 (5mg):
The first dose increase. Most people experience more pronounced appetite suppression here — the point where food noise genuinely quietens. Nausea and gastrointestinal side effects are most common in the days following each dose increase.
Weeks 9–16 (7.5mg–10mg):
Significant weight loss typically becomes visible in this phase. Energy levels improve as the body adapts. Side effects usually stabilise between dose increases.
Weeks 17–24 (12.5mg–15mg):
The maintenance phase. Maximum appetite suppression and weight loss rate. Some people plateau at lower doses and do not need to progress to 15mg — your prescriber will guide this decision.
Beyond week 24:
Weight loss continues but typically slows as you approach your body’s new set point. This is normal. Clinical trials measure results over 72 weeks — do not judge the medication by 12-week results.
Mounjaro Side Effects: What UK Patients Should Know
The most common side effects are gastrointestinal — nausea, diarrhoea, constipation, and vomiting. They are most pronounced in the first few weeks and after each dose increase.
Managing nausea: Eat smaller portions, avoid fatty and spicy foods, stay upright after eating, and eat slowly. Ginger tea can help. If nausea is severe, contact your provider — they may recommend staying at the current dose longer before increasing.
Managing diarrhoea: Stay hydrated. Electrolyte supplements are particularly important here. Avoid high-fat and high-sugar foods which worsen symptoms. Managing constipation: Increase fibre intake, drink at least 2 litres of water daily, and consider a fibre supplement. Light walking helps stimulate gut motility.
Hair loss: Some Mounjaro users experience hair thinning 3–6 months into treatment. This is not a direct drug side effect — it is a response to rapid weight loss and reduced calorie intake. Maintaining adequate protein intake (1.2–1.6g per kg of body weight daily) and taking a good multivitamin significantly reduces the risk. Hair typically regrows within 6–12 months once weight stabilises.
Muscle loss: Rapid weight loss on Mounjaro can include loss of lean muscle alongside fat. Resistance training and prioritising protein at every meal are the two most effective countermeasures. See our Supplements Guide for the full nutrition approach.
Serious side effects (rare): Pancreatitis, gallbladder problems, kidney issues, and severe allergic reactions are rare but require immediate medical attention. Seek emergency care if you experience severe abdominal pain, difficulty breathing, or signs of an allergic reaction.
Mounjaro vs Wegovy in the UK: Which Is Better?
Both are excellent medications. The right choice depends on your situation.
Mounjaro produces more weight loss in every head-to-head trial conducted to date. In the SURMOUNT-5 trial, tirzepatide produced approximately 20% weight loss versus 14% for semaglutide over 72 weeks.
Mounjaro costs more in the UK private market. After the September 2025 price increase, the gap between Mounjaro and Wegovy at private rates is significant — particularly at higher doses. Mounjaro has stronger side effects — more pronounced nausea and diarrhoea than semaglutide in comparative data. For people who are sensitive to GI side effects, Wegovy may be easier to tolerate.
NHS access: Both are now available through NHS pathways, with Mounjaro expanding more rapidly through GP prescribing from 2026. Wegovy remains primarily a specialist service medication.
A practical approach: if cost is a major factor, start with Wegovy. If you want maximum results and can manage the side effects and cost, Mounjaro is the stronger option.
Frequently Asked Questions
Can my GP prescribe Mounjaro for weight loss?
Yes, from April 2026 GPs can prescribe Mounjaro for obesity through the NHS QOF scheme. From June 2026 the BMI threshold drops to 35 with four qualifying conditions. Check with your GP whether your practice is participating.
Is Mounjaro the same as tirzepatide? Yes. Mounjaro is the brand name for tirzepatide in the UK. There is no separate UK brand equivalent of Zepbound — Mounjaro is used for both diabetes and weight management.
Why did Mounjaro prices go up so much?
Eli Lilly increased the UK list price by up to 170% on 1 September 2025 to align with pricing in other European markets. Most private providers passed this increase to patients. The NHS is insulated from this change as it negotiates prices directly with the manufacturer.
Can I get Mounjaro online in the UK legally?
Yes, provided you use a GPhC-registered pharmacy and the prescription is issued by a UK-registered prescriber following a legitimate medical assessment. Buying from unregistered sources, overseas websites, or social media is illegal and dangerous.
How long does it take to start seeing results?
Most people notice reduced appetite within 1–2 weeks. Visible weight loss typically begins at 4–8 weeks. Maximum results are measured over 72 weeks of continuous treatment.
What happens if I stop taking Mounjaro?
Most people regain a significant portion of their lost weight within 12 months of stopping. GLP-1 medications address the biological drivers of obesity while you are taking them — they do not permanently change your metabolism. Stopping treatment should always be discussed with your prescriber rather than done abruptly.